134 related articles for article (PubMed ID: 1349890)
1. Activation of alpha 1- and alpha 2-adrenoceptors inhibits noradrenaline release in rabbit renal arteries: effects of pertussis toxin and N-ethylmaleimide.
Rump LC; Wolk V; Ruff G; Schollmeyer P
J Auton Pharmacol; 1992 Apr; 12(2):97-108. PubMed ID: 1349890
[TBL] [Abstract][Full Text] [Related]
2. Prejunctional alpha 2-adrenoceptors in mouse atria function through G-proteins which are sensitive to N-ethylmaleimide, but not pertussis toxin.
Murphy TV; Foucart S; Majewski H
Br J Pharmacol; 1992 Aug; 106(4):871-6. PubMed ID: 1356569
[TBL] [Abstract][Full Text] [Related]
3. Alpha2-adrenoceptor-mediated inhibition of cultured sympathetic neurons: changes in alpha2A/D-adrenoceptor-deficient mice.
Trendelenburg AU; Nörenberg W; Hein L; Meyer A; Starke K
Naunyn Schmiedebergs Arch Pharmacol; 2001 Jan; 363(1):110-9. PubMed ID: 11191829
[TBL] [Abstract][Full Text] [Related]
4. Alpha 2-adrenoceptor activation inhibits noradrenaline release in human and rabbit isolated renal arteries.
Rump LC; Ruff G; Wolk V; Schollmeyer P
Eur J Pharmacol; 1991 Apr; 196(3):277-83. PubMed ID: 1680052
[TBL] [Abstract][Full Text] [Related]
5. Pertussis toxin differentiates between alpha 1- and alpha 2-adrenoceptor-mediated inhibition of noradrenaline release from rat kidney cortex.
Murphy TV; Majewski H
Eur J Pharmacol; 1990 Apr; 179(3):435-9. PubMed ID: 2163856
[TBL] [Abstract][Full Text] [Related]
6. N-ethylmaleimide diminishes alpha 2-adrenoceptor-mediated effects on norepinephrine release in rat tail arteries.
Allgaier C; Weber HD; Hertting G; Illes P
J Cardiovasc Pharmacol; 1992 Jun; 19(6):958-65. PubMed ID: 1376819
[TBL] [Abstract][Full Text] [Related]
7. Methoxamine inhibits noradrenaline release through activation of alpha 1- and alpha 2-adrenoceptors in rat isolated kidney: involvement of purines and prostaglandins.
Bohmann C; Schollmeyer P; Rump LC
Naunyn Schmiedebergs Arch Pharmacol; 1993 Mar; 347(3):273-9. PubMed ID: 8097565
[TBL] [Abstract][Full Text] [Related]
8. Pertussis toxin does not attenuate alpha 2-adrenoceptor mediated inhibition of noradrenaline release in mouse atria.
Musgrave I; Marley P; Majewski H
Naunyn Schmiedebergs Arch Pharmacol; 1987 Sep; 336(3):280-6. PubMed ID: 2891042
[TBL] [Abstract][Full Text] [Related]
9. Involvement of pertussis toxin-sensitive and -insensitive mechanisms in alpha-adrenoceptor modulation of noradrenaline release from rat sympathetic neurones in tissue culture.
Hill CE; Powis DA; Hendry IA
Br J Pharmacol; 1993 Sep; 110(1):281-8. PubMed ID: 8106104
[TBL] [Abstract][Full Text] [Related]
10. Modulation of noradrenaline release in slices of rat kidney cortex through alpha 1- and alpha 2-adrenoceptors.
Murphy TV; Majewski H
Eur J Pharmacol; 1989 Oct; 169(2-3):285-95. PubMed ID: 2553450
[TBL] [Abstract][Full Text] [Related]
11. Effects of endogenous and synthetic prostanoids, the thromboxane A2 receptor agonist U-46619 and arachidonic acid on [3H]-noradrenaline release and vascular tone in rat isolated kidney.
Rump LC; Schollmeyer P
Br J Pharmacol; 1989 Jul; 97(3):819-28. PubMed ID: 2503228
[TBL] [Abstract][Full Text] [Related]
12. Presynaptic imidazoline receptors and non-adrenoceptor [3H]-idazoxan binding sites in human cardiovascular tissues.
Molderings GJ; Likungu J; Jakschik J; Göthert M
Br J Pharmacol; 1997 Sep; 122(1):43-50. PubMed ID: 9298527
[TBL] [Abstract][Full Text] [Related]
13. Modulation of norepinephrine release through alpha 1- and alpha 2-adrenoceptors in rat isolated kidney.
Rump LC; Majewski H
J Cardiovasc Pharmacol; 1987 Apr; 9(4):500-7. PubMed ID: 2438514
[TBL] [Abstract][Full Text] [Related]
14. Dopaminergic and alpha-adrenergic control of neurotransmission in human right atrium.
Rump LC; Riera-Knorrenschild G; Schwertfeger E; Bohmann C; Spillner G; Schollmeyer P
J Cardiovasc Pharmacol; 1995 Sep; 26(3):462-70. PubMed ID: 8583789
[TBL] [Abstract][Full Text] [Related]
15. The inhibition of alpha 1-adrenoceptor-mediated contractions of rabbit pulmonary artery by Ca2+-withdrawal, pertussis toxin and N-ethylmaleimide is dependent on agonist intrinsic efficacy.
Liebau S; Hohlfeld J; Förstermann U
Naunyn Schmiedebergs Arch Pharmacol; 1989 May; 339(5):496-502. PubMed ID: 2570359
[TBL] [Abstract][Full Text] [Related]
16. Alpha 2-autoreceptor subclassification in rat isolated kidney by use of short trains of electrical stimulation.
Bohmann C; Schollmeyer P; Rump LC
Br J Pharmacol; 1993 Jan; 108(1):262-8. PubMed ID: 8094025
[TBL] [Abstract][Full Text] [Related]
17. Postjunctional alpha-adrenoceptors in the rabbit isolated distal saphenous artery: indirect sensitivity to prazosin of responses to noradrenaline mediated via postjunctional alpha 2-adrenoceptors.
Dunn WR; McGrath JC; Wilson VG
Br J Pharmacol; 1991 Jun; 103(2):1484-92. PubMed ID: 1679360
[TBL] [Abstract][Full Text] [Related]
18. Noradrenaline stimulates 5-hydroxytryptamine release from mouse ileal tissues via alpha(2)-adrenoceptors.
Hirafuji M; Ogawa T; Kato K; Hamaue N; Endo T; Parvez H; Minami M
Eur J Pharmacol; 2001 Dec; 432(2-3):149-52. PubMed ID: 11740950
[TBL] [Abstract][Full Text] [Related]
19. Protein kinase C activation and alpha 2-autoreceptor-modulated release of noradrenaline.
Allgaier C; Hertting G; Huang HY; Jackisch R
Br J Pharmacol; 1987 Sep; 92(1):161-72. PubMed ID: 2822193
[TBL] [Abstract][Full Text] [Related]
20. A study of ATP as a sympathetic cotransmitter in human saphenous vein.
Rump LC; von Kügelgen I
Br J Pharmacol; 1994 Jan; 111(1):65-72. PubMed ID: 7912156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
